(Q30975955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Brain metastasis responding to gefitinib alone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Tony Mok

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Annette N Y Poon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Simon S M Ho

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

174-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer. II: Clinical effects.

5 January 2020

cites work

1 reference

Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study

21 January 2018

1 reference

ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial

21 January 2018

1 reference

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

21 January 2018

1 reference

A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain

21 January 2018

1 reference

Lung cancer. Palliative care

21 January 2018

1 reference

Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. a multicentre phase II study

21 January 2018

1 reference

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

21 January 2018

1 reference

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

21 January 2018

1 reference

Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancer.

21 January 2018

1 reference

Treatment of relapsed small-cell lung cancer--a focus on the evolving role of topotecan

21 January 2018

1 reference

Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000081005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539923%20AND%20SRC:MED&resulttype=core&format=json

release_4sgirsyuyzbidd5ii7ttds5e3i

5 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4sgirsyuyzbidd5ii7ttds5e3i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference